Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.49 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27729872 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL27694313 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL27676770 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL19130076 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL4254874 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL28172728 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL27709317 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL27479265 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL27952097 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 | |
| SCHEMBL16268113 | 0.98 | NAAA (0.62) | NAAATSHRHPGDHTTRAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 712 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220009899-A1 | PROCESS AND COMPOUNDS FOR PREPARATION OF CANNABINOIDS | EMBIO LIMITED (IN) | 2022-01-13 | — | — | US | claimed |
| EP-2751248-B1 | SOLID TEXTILE-TREATING COMPOSITIONS | Henkel IP & Holding GmbH (DE) | 2021-06-09 | — | — | EP | claimed |
| WO-2020099942-A1 | PROCESS AND COMPOUNDS FOR PREPARATION OF CANNABINOIDS | EMBIO LIMITED (IN) | 2020-05-22 | — | — | WO | claimed |
| US-10550356-B2 | Solid and liquid textile-treating compositions | Henkel IP & Holding GmbH (DE) | 2020-02-04 | — | — | US | claimed |
| CN-106946877-B | A kind of preparation method and the compound of nitrogenous fused heterocyclic compound | 沈阳师范大学 | 2019-05-24 | — | — | CN | claimed |
| CN-106946877-A | The preparation method and the compound of a kind of nitrogenous fused heterocyclic compound | 沈阳师范大学 | 2017-07-14 | — | — | CN | claimed |
| CN-106632243-A | Pyrrolidine derivative | 华领医药技术（上海）有限公司 | 2017-05-10 | — | — | CN | claimed |
| EP-2468708-B1 | Catalytic decarboxylative cross-ketonisation of aryl- and alkylcarboxylic acids using iron catalysts | COGNIS IP MAN GMBH (DE) | 2016-11-09 | — | — | EP | claimed |
| CN-104326905-B | A kind of aryl alkyl carboxylic acid polyoxyethylene ester and its preparation method and application | DALIAN DONGFANG INNOVATION SCIENCE & TECHNOLOGY CO., LTD. (CN) | 2016-05-18 | — | — | CN | claimed |
| CN-105121424-A | mGluR regulators | HUA MEDICINE SHANGHAI LTD | 2015-12-02 | — | — | CN | claimed |
| CN-1184472-A | Reversible protease inhibitors | ARRIS PHARM CORP (US) | 1998-06-10 | — | — | CN | claimed |
| CN-1177955-A | Process for preparing retroviral protease inhibitor intermediates | SEARLE & CO (US) | 1998-04-01 | — | — | CN | claimed |
| CN-1175249-A | 3-aryl-1, 2, 4-triazole derivatives having herbicidal properties | BAYER AG (DE) | 1998-03-04 | — | — | CN | claimed |
| CN-1161037-A | Substituted spiroalkylamino and spiroalkoxy heterocycles, process for their preparation and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1997-10-01 | — | — | CN | claimed |
| CN-1148383-A | Heterocyclylamino-and heterocyclyloxy-cycloalkyl derivatives, their preparation and their use as pesticides and fungicides | HOECHST SCHERING AGREVO GMBH (DE) | 1997-04-23 | — | — | CN | claimed |
| CN-1112119-A | 13-substituted milbemycin derivatives, their preparation and use | SANKYO CO (JP) | 1995-11-22 | — | — | CN | claimed |
| CN-1092769-A | Cyclic urea derivatives, the method that contains the pharmaceutical composition of these compounds and prepare them | THOMAE GMBH DR K (DE) | 1994-09-28 | — | — | CN | claimed |
| CN-1082040-A | Indoles | PFIZER RES & DEV (IE) | 1994-02-16 | — | — | CN | claimed |
| CN-1052481-A | Lipoid category-A with immunocompetence and anti-tumor activity is like thing | SANKYO CO (JP) | 1991-06-26 | — | — | CN | claimed |
| US-4285801-A | PROTECTIVE COATINGS OF FLUOROPOLYMERS AS DISPERSANTS FOR SUSPENDED PARTICLES STABILITY | XEROX CORPORATION (US) | 1981-08-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220009899-A1 | PROCESS AND COMPOUNDS FOR PREPARATION OF CANNABINOIDS | CNR2, CNR1, DEGS1 | NAAA 627/4885TSHR 1549/4885HPGD 2608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.